Search
Phencyclidine
go.drugbank.com/drugs/DB03575ExperimentalIllicitAs a drug of abuse, it is known as PCP and Angel Dust. … Like ketamine, it can produce a dissociative state. It exerts its pharmacological action through inhibition of NMDA receptors (receptors, N-methyl-D-aspartate).
ECT-001 expanded cord blood
go.drugbank.com/drugs/DB21745Investigational[L52013] It is being investigated in hematopoietic cell transplantation as ECT-001 expanded cord blood can demonstrate enhanced stem cell proliferation and engraftment compared to untreated UBCs. … ECT-001 expanded cord blood is umbilical cord blood (UCB) that has been co-cultured and expanded with the small molecule agonist [UM-171].
Synonyms: ECT-001 expanded UCB, ECT-001 expanded cord bloodAnthoxanthum odoratum
go.drugbank.com/drugs/DB14163ApprovedAnthoxanthum odoratum allergenic extract is used in allergenic testing.
Bupranolol
go.drugbank.com/drugs/DB08808ExperimentalIt does not have intrinsic sympathomimetic activity (ISA), but does have strong membrane stabilizing activity.
Stearic acid
go.drugbank.com/drugs/DB03193ApprovedIt is a waxy solid.
Mixtures: Huile D'onagre Vitamin EAxitinib
go.drugbank.com/drugs/DB06626ApprovedInvestigational[A179398] It is most commonly marketed under the name Inlyta® and is available in oral formulations. … It is reported to exhibit potency that is 50-450 times higher than that of the first generation VEGFR inhibitors.[L6676] Axitinib is an indazole derivative.
Synonyms: N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamideProducts: INLYTA TABLETS 1MG, INLYTA TABLETS 5MGLarotrectinib
go.drugbank.com/drugs/DB14723ApprovedInvestigationalIt was notable for being the second tissue-agnostic chemotherapy ever approved by the FDA.[L4847]. On April 10, 2025, the FDA granted full drug approval.[L52805]
Products: VITRAKVI 25 MG SERT KAPSÜL, 56 ADET, VITRAKVI 100 MG SERT KAPSÜL, 56 ADETOlokizumab
go.drugbank.com/drugs/DB13127Investigational[A241185, A241175] Olokizumab is a humanized anti-IL-6 IgG4κ antibody that directly blocks gp130 binding at IL-6 Site 3.[A241045]